ADAM17 and breast cancer: Similar to the DLD‐1 cell system, we removed endogenous ADAM17 using CRISPR/Cas9 from the mouse breast cancer cell line 4T1 and exogenously expressed the different ADAM17 variants (Figs 6D, and EV4I and J).